Flutamide

氟他胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFlutamide
Drug Alias NameFUGEREL氟鲁胺flutamidum氟化酰胺flutamida +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsPolycystic Ovary Syndrome
Global Approved IndicationsProstatic Neoplasms
Approved Indications in ChinaProstatic Neoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date1989/01/27
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSchering-Plough Labo Nv
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los AngelesUniversity Of VirginiaShanghai Fudan Forward Pharmaceutical Co Ltd
Inactive CompaniesThe University Of ArizonaNational Cancer InstituteSchering Ag
Active IndicationsProstatic NeoplasmsPolycystic Ovary Syndrome
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeL02BB01
Related LinksWikipediaDrugBankKEGG